Yüklüyor......

Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy: Implications for Vaccine Clinical Trial Design

PURPOSE: We previously reported the first randomized study of any kind in patients with nonmetastatic, castrate-resistant prostate cancer. The study employed vaccine, the hormone nilutamide, and the combined therapy (crossover for each arm) with an endpoint of time to progression. We now report surv...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Madan, Ravi A., Gulley, James L., Schlom, Jeffrey, Steinberg, Seth M., Liewehr, David J., Dahut, William L., Arlen, Philip M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2682417/
https://ncbi.nlm.nih.gov/pubmed/18628467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-5048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!